Ownership history in FORT, L.P. · 19 quarters on record
This page tracks every 13F SEC filing in which FORT, L.P. reported a position in VERTEX PHARMACEUTICALS INC (VRTX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2024 Q2 | REDUCED | 485 | -149 | -23.5% | 0.58% | $227K | $468.72 |
| 2024 Q1 | REDUCED | 634 | -116 | -15.5% | 0.67% | $265K | $418.01 |
| 2023 Q4 | REDUCED | 750 | -82 | -9.9% | 0.75% | $305K | $406.89 |
| 2023 Q3 | REDUCED | 832 | -37 | -4.3% | 0.80% | $289K | $347.74 |
| 2023 Q2 | REDUCED | 869 | -137 | -13.6% | 0.81% | $306K | $351.91 |
| 2023 Q1 | REDUCED | 1,006 | -501 | -33.2% | 0.82% | $317K | $315.07 |
| 2022 Q4 | REDUCED | 1,507 | -574 | -27.6% | 0.66% | $435K | $288.78 |
| 2022 Q3 | REDUCED | 2,081 | -777 | -27.2% | 0.75% | $603K | $289.54 |
| 2022 Q2 | REDUCED | 2,858 | -361 | -11.2% | 0.55% | $805K | $281.79 |
| 2022 Q1 | REDUCED | 3,219 | -69 | -2.1% | 0.32% | $840K | $260.97 |
As of 2025 Q4 — sorted by position size